Oklahoma 2025 Regular Session

Oklahoma Senate Bill SB552 Latest Draft

Bill / Amended Version Filed 04/21/2025

                             
 
SB552 HFLR 	Page 1 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
HOUSE OF REPRESENTATIVES - FLOOR VERSION 
 
STATE OF OKLAHOMA 
 
1st Session of the 60th Legislature (2025) 
 
ENGROSSED SENATE 
BILL NO. 552 	By: Hines of the Senate 
 
  and 
 
  Duel of the House 
 
 
 
 
An Act relating to public safety; defining terms; 
prohibiting state agencies from certain use of 
biotechnology; prohibiting certain contract; 
providing for codification; and providing conditional 
effective date. 
 
 
 
 
 
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA: 
SECTION 1.     NEW LAW     A new section of law to be codified 
in the Oklahoma Statutes as Section 52 of Title 74, unless there is 
created a duplication in numbering, reads as follows: 
A.  For purposes of this section: 
1.  “Biotechnology company of concern ” means an entity 
designated by the federal government to be under the control of a 
foreign adversary and that poses a risk to national security based 
on the company’s research of multiomic data collection; and 
2.  “Multiomics” means a biological analysis method that 
combines data from mu ltiple research areas, including, but not   
 
SB552 HFLR 	Page 2 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
limited to, genomics, tra nscriptomics, proteomics, epigenomics, and 
metabolomics in order to gain a comprehensive understanding of 
complex biological processes . 
B.  Any state agency that receives federal or state funds shall 
not be authorized to use or procure any biotechnology equipment or 
service that originates from a company designated by the federal 
government to be a biotechnology company of concern nor shall any 
such state agency contract with an entity that uses or procures such 
biotechnology. 
SECTION 2.  This act shall take effect upon the enac tment of a 
federal law that prohibits entities that receive federal funds from 
using biotechnology that is from a company associated with a foreign 
adversary. 
 
COMMITTEE REPORT BY: COMMITTEE ON JUDICIARY AND PUBLIC SAFETY , dated 
04/17/2025 – DO PASS.